Related Experiment Video
Updated: Jul 22, 2026

08:05
Murine Model of Allergen Induced Asthma
Published on: May 14, 2012
Inhalation challenge with ragweed pollen in ragweed-sensitive asthmatics
The Journal of Allergy and Clinical Immunology
|March 1, 1983
Summary
Whole ragweed pollen inhalation does not trigger asthma attacks in sensitive individuals. However, inhaled ragweed pollen fragments can cause significant bronchoconstriction, suggesting small particles are key triggers for fall asthma.
Area of Science:
- Allergology
- Pulmonology
- Environmental Health
Background:
- Ragweed pollen is a common allergen implicated in seasonal asthma.
- The precise mechanism by which ragweed pollen triggers asthmatic symptoms remains under investigation.
Purpose of the Study:
- To investigate the role of inhaled whole ragweed pollen versus pollen fragments in inducing bronchoconstriction in ragweed-sensitive asthmatic patients.
Main Methods:
- Quantitative pollen inhalation challenges using a turbo-inhaler in adult subjects with confirmed ragweed sensitivity.
- Assessment of bronchial response to whole pollen grains and fragmented pollen (1-8 micrometers).
- Evaluation of response with and without atropine pretreatment.
Main Results:
- Inhalation of whole ragweed pollen (up to 7640 grains) did not induce bronchoconstriction in any of the 12 subjects.
- Nasal challenge with whole pollen caused hay fever symptoms but no bronchospasm.
- Inhalation of fragmented ragweed pollen (59-20,000 equivalents) caused a 35% fall in airways conductance in 6 of 7 subjects.
- Atropine pretreatment did not affect the response to pollen fragments, ruling out an irritant effect.
Conclusions:
- Whole ragweed pollen may not be the primary cause of fall asthma in allergic individuals.
- Small-particle allergens, potentially derived from ragweed pollen fragments, are more likely culprits for fall seasonal asthma.
- Further research should focus on identifying and characterizing these smaller allergenic particles.
More Related Videos
Related Concept Videos
Allergic Reactions
Overview
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Asthma-I: Introduction
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
Asthma-IV: Diagnostic and Management
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Asthma I: Introduction
Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Asthma III: Clinical Manifestations
Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...

